Nomura Asset Management’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.22M Buy
542,500
+11,900
+2% +$209K 0.02% 460
2025
Q4
$8.99M Buy
530,600
+20,200
+4% +$359K 0.02% 460
2025
Q3
$9.2M Buy
510,400
+6,400
+1% +$108K 0.02% 457
2025
Q2
$7.99M Buy
504,000
+14,800
+3% +$225K 0.02% 498
2025
Q1
$8.27M Buy
489,200
+6,230
+1% +$104K 0.03% 460
2024
Q4
$8.19M Buy
482,970
+10,300
+2% +$181K 0.02% 460
2024
Q3
$8.58M Sell
472,670
-730
-0.2% -$12.9K 0.03% 439
2024
Q2
$7.8M Buy
473,400
+24,100
+5% +$369K 0.03% 435
2024
Q1
$6.36M Buy
449,300
+17,973
+4% +$271K 0.02% 481
2023
Q4
$7.43M Sell
431,327
-83,400
-16% -$1.27M 0.03% 439
2023
Q3
$7.86M Buy
514,727
+8,200
+2% +$146K 0.04% 398
2023
Q2
$9.55M Buy
506,527
+14,700
+3% +$284K 0.04% 357
2023
Q1
$9.51M Buy
491,827
+13,537
+3% +$273K 0.05% 347
2022
Q4
$9.22M Buy
478,290
+15,297
+3% +$300K 0.05% 330
2022
Q3
$9.65M Buy
462,993
+216,660
+88% +$5.51M 0.06% 314
2022
Q2
$6.88M Buy
246,333
+42,319
+21% +$1.26M 0.04% 378
2022
Q1
$6.39M Buy
204,014
+8,810
+5% +$278K 0.03% 430
2021
Q4
$6.52M Buy
195,204
+18,324
+10% +$612K 0.03% 436
2021
Q3
$5.25M Sell
176,880
-5,544
-3% -$162K 0.03% 456
2021
Q2
$4.87M Sell
182,424
-2,800
-2% -$79.2K 0.03% 489
2021
Q1
$5.11M Buy
185,224
+1,980
+1% +$55.4K 0.03% 454
2020
Q4
$5.05M Buy
183,244
+508
+0.3% +$13.4K 0.03% 418
2020
Q3
$4.75M Buy
182,736
+6,700
+4% +$176K 0.04% 393
2020
Q2
$4.67M Sell
176,036
-61,800
-26% -$1.58M 0.04% 374
2020
Q1
$5.78M Buy
237,836
+90,300
+61% +$2.73M 0.06% 267
2019
Q4
$4.47M Buy
147,536
+4,000
+3% +$120K 0.04% 382
2019
Q3
$4.22M Buy
143,536
+180
+0.1% +$5.03K 0.04% 369
2019
Q2
$3.93M Buy
143,356
+13,626
+11% +$384K 0.04% 379
2019
Q1
$3.71M Sell
129,730
-1,670
-1% -$46.4K 0.04% 390
2018
Q4
$3.33M Buy
131,400
+2,790
+2% +$73.9K 0.04% 375
2018
Q3
$3.43M Buy
128,610
+4,640
+4% +$128K 0.03% 398
2018
Q2
$3.34M Sell
123,970
-7,773
-6% -$198K 0.03% 400
2018
Q1
$3.48M Buy
131,743
+7,800
+6% +$208K 0.04% 365
2017
Q4
$3.72M Buy
123,943
+860
+0.7% +$26K 0.04% 345
2017
Q3
$3.67M Sell
123,083
-8,120
-6% -$247K 0.05% 325
2017
Q2
$4.08M Buy
131,203
+32,110
+32% +$1.01M 0.05% 300
2017
Q1
$3.12M Buy
99,093
+840
+0.9% +$25.5K 0.04% 353
2016
Q4
$2.86M Buy
98,253
+6,120
+7% +$180K 0.05% 335
2016
Q3
$3M Sell
92,133
-5,105
-5% -$169K 0.05% 332
2016
Q2
$3.15M Buy
97,238
+10,581
+12% +$319K 0.06% 312
2016
Q1
$2.55M Buy
86,657
+12,557
+17% +$348K 0.05% 349
2015
Q4
$2M Buy
74,100
+4,300
+6% +$111K 0.04% 392
2015
Q3
$1.71M Buy
69,800
+8,100
+13% +$200K 0.03% 420
2015
Q2
$1.48M Buy
61,700
+6,900
+13% +$176K 0.03% 477
2015
Q1
$1.53M Buy
54,800
+7,585
+16% +$213K 0.03% 472
2014
Q4
$1.29M Buy
47,215
+4,850
+11% +$123K 0.02% 509
2014
Q3
$983K Buy
42,365
+13,850
+49% +$336K 0.02% 590
2014
Q2
$687K Buy
28,515
+1,125
+4% +$26.8K 0.01% 704
2014
Q1
$624K Buy
27,390
+1,600
+6% +$34.9K 0.01% 729
2013
Q4
$508K Sell
25,790
-2,050
-7% -$43.5K 0.01% 764
2013
Q3
$586K Buy
27,840
+18,640
+203% +$402K 0.01% 710
2013
Q2
$207K Buy
+9,200
New +$221K ﹤0.01% 823

Other funds holding HR